About Jon Freeman
Form D filings for Gila Therapeutics from 2016 to 2023 list Jon Freeman as executive officer.
Jon Freeman first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Jon Freeman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jon Freeman works with at each company, as listed on that company's latest Form D.
Gila Therapeutics, Inc. · Form D, Dec 6, 2023
TB
Timothy Barberich
Director
CS
Christopher De Souza
Director
PT
Praveen Tyle
Director
TV
Thomas Vasicek
Executive officer
RH
Richard Horan
Director
SS
Scott Schorer
Cief Executive Officer and director
SK
Sangeeta Kashyap
Executive officer